Form 4: Aspira Women's Health Director Exercises Stock Options, Increases Holdings

Director Ellen O'Connor Vos converted vested restricted stock units into 5,312 shares of Aspira Women's Health common stock on December 31, 2024.

Summary

• Ellen O'Connor Vos, a director at Aspira Women's Health Inc., converted 5,312 restricted stock units (RSUs) into common stock on December 31, 2024.
• These RSUs were part of a grant of 21,250 RSUs awarded on August 22, 2024, with 5,312 vesting on December 31, 2024.
• The conversion of the RSUs resulted in Ms. Vos acquiring 5,312 shares of common stock at a price of $0.00 per share.
• Following the transaction, Ms. Vos directly owns 63,364 shares of Aspira Women's Health common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of a director converting vested stock options. It is a neutral event with a slightly positive sentiment due to the director increasing their stake in the company.

Positives

• The conversion of RSUs into common stock indicates the director's continued investment in the company.
• The increase in direct ownership aligns the director's interests with those of other shareholders.

Industry Context

This is a standard SEC Form 4 filing, which is a routine disclosure for company insiders when they trade company stock. It is common for directors to receive stock-based compensation, and the vesting and conversion of these units is a normal part of that process.

Comparison to Industry Standards

• Stock-based compensation is a common practice across the industry, particularly for directors and executives.
• The vesting schedule and terms of the RSUs are likely consistent with industry norms for similar roles.
• The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for all publicly traded companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Aspira Women's Health, stock options, restricted stock units, insider trading, beneficial ownership, director, equity